My Drug's Better Than Your Drug

Arlene Weintraub; Pat Wechsler

首页> 外文期刊>Business week >My Drug's Better Than Your Drug

【24h】

My Drug's Better Than Your Drug

机译：我的药物胜过您的药物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Roche announced on Dec. 2 that its experimental diabetes drug performed better in a trial than Merck's $2 billion-a-year blockbuster Januvia. This gave the Swiss giant potent bragging rights-and it was part of a pattern. Six weeks earlier, Roche trumpeted data showing its treatment was superior to a diabetes drug from Eli Lilly. Next year it will wrap up two more trials, pitting its drug against diabetes products from sanofi-aventis and Japan's Takeda.

机译：罗氏公司在12月2日宣布，其试验性糖尿病药物在试验中的表现优于默克公司每年20亿美元的巨片Januvia。这赋予了瑞士巨人强大的吹牛权利-这是一种模式的一部分。六周前，罗氏（Roche）大肆宣传的数据显示，其治疗优于礼来（Eli Lilly）的糖尿病药物。明年它将再进行两项试验，将其药物与赛诺菲-安万特和日本武田的糖尿病产品抗衡。

著录项

来源
《Business week》 |2009年第21期|72|共1页
作者
Arlene Weintraub; Pat Wechsler;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Risk of drug-drug interactions in out-hospital drug dispensings in France: results from the DRUG-Drug Interaction Prevalence Study (DRUG-DIPS) [J] . Letinier L., Cossin S., Mansiaux Y., Fundamental & clinical pharmacology. . 2018,第S1期

机译：法国外院药物分配药物 - 药物互动风险：药物 - 药物相互作用普遍研究的结果（药物 - 浸渍）
2. Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability [J] . Michael J. Cross, James E. Sidaway, Emma L. Wilkinson Biology Open . 2016,第10期

机译：心脏毒性药物赫赛汀和阿霉素抑制心脏微血管内皮细胞屏障形成，导致药物渗透性增强心脏毒性药物赫赛汀和阿霉素抑制心脏微血管内皮细胞屏障形成，导致药物通透性增加心脏毒性药物赫赛汀和阿霉素抑制心脏微血管内皮细胞屏障形成，导致药物增多渗透性
3. Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study [J] . Louis Létinier, Sébastien Cossin, Yohann Mansiaux, Frontiers in Pharmacology . 2019,第4期

机译：法国外院药物分配药物 - 药物互动的风险：药物 - 药物相互作用普遍研究的结果
4. PM-TOM: A Method for Finding Personalized Polypharmacy Therapies with Minimal Adverse Drug-Drug, Drug-Gene and Drug-Condition Interactions [C] . Adnan Kulenovic, Azra Lagumdzija-Kulenovic Medical Informatics Europe Conference . 2020

机译：PM-TOM：一种以最小的不良药物 - 药物，药物 - 基因和药物条件相互作用寻找个性化多酚疗法的方法
5. The predictive relationship of drug-abstinence self-efficacy, health locus of control, drug use severity, and HIV illness severity on readiness to change drug use among out-of-treatment HIV+ drug users. [D] . Hall, Joan. 2007

机译：戒毒HIV +吸毒者中戒毒自我效能，控制的健康场所，药物使用严重性和HIV疾病严重性与准备改变药物使用之间的预测关系。
6. Optimising Seniors’ Metabolism of Medications and Avoiding Adverse Drug Events Using Data on How Metabolism by Their P450 Enzymes Varies with Ancestry and Drug–Drug and Drug–Drug–Gene Interactions [O] . Roger E. Thomas 2020

机译：优化老年人的药物代谢避免使用关于代谢对代谢的补充剂的不良药物随着血统和药物 - 药物和药物 - 药物 - 基因相互作用而变化
7. The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug–Drug Interactions: Drug–Gene, Drug–Gene–Gene and Drug–Drug–Gene Interactions [O] . Martina Hahn, Sibylle C. Roll 2021

机译：药物发生对药代动力学药物 - 药物相互作用临床相关性的影响：药物 - 基因，药物 - 基因和药物 - 药物 - 基因相互作用
8. Drug Abuse Prevention Package: Drug Abuse Prevention: What Works; CommunityReadiness for Drug Abuse Prevention; Issues, Tips, and Tools; Drug Abuse Prevention and Community Readiness: Training Facilitator's Manual [R] . Kumpfer, K. L., Baxley, G. B., Wheeler, J., 1997

机译：药物滥用预防包：药物滥用预防：什么有效;社区对药物滥用预防的预防;问题，提示和工具;药物滥用预防和社区准备：培训辅导员手册

My Drug's Better Than Your Drug

摘要

著录项

相似文献

相关主题

期刊订阅